<?xml version="1.0" encoding="UTF-8"?>
<p>The recent studies on drug repositioning/repurposing involve a variety of computational methods, such as network analysis, text mining, machine learning, and structure‐based drug repositioning (SBDR) [
 <xref rid="feb213806-bib-0019" ref-type="ref">19</xref>, 
 <xref rid="feb213806-bib-0020" ref-type="ref">20</xref>, 
 <xref rid="feb213806-bib-0021" ref-type="ref">21</xref>, 
 <xref rid="feb213806-bib-0022" ref-type="ref">22</xref>, 
 <xref rid="feb213806-bib-0023" ref-type="ref">23</xref>, 
 <xref rid="feb213806-bib-0024" ref-type="ref">24</xref>]. Among these methods, SBDR is the most promising to find specific drugs toward a defined target protein, and it prompted the quick structure analyses of SARS‐CoV‐2 3C‐like proteinase and surface glycoprotein [
 <xref rid="feb213806-bib-0008" ref-type="ref">8</xref>, 
 <xref rid="feb213806-bib-0025" ref-type="ref">25</xref>].
</p>
